Abstract
Elevations of LDL and plasma cholesterol are established predictive risk factors for predisposing to early coronary heart disease. Conversely, HDL has a protective anti-atherogenic effect. The hyperlipidemias are classified according to a genetic basis (primary) and the result of other diseases (secondary). Diet is an important and modifiable determinant of the lipid concentration in plasma. Restricting saturated fat consumption, increasing intake of polyunsaturated fat and reducing dietary cholesterol are key to hyperlipidemias with elevated LDL. Weight reduction, decreased alcohol consumption, and in some individuals, restriction of simple sugar intake are the primary means for treating hyperlipidemias.
摘要
相似文献
1
Lipoproteins and heart disease.
Nurse Pract. 1983 May;8(5):68-9, 72.
2
[Hyperlipoproteinemia].
Ned Tijdschr Geneeskd. 1979 Mar 14;123(15):617-28.
3
The lipoprotein apoproteins. Their role in normal lipid transport and dyslipoproteinemia.
Ann Biol Clin (Paris). 1974;32(1):1-8.
4
Diabetic dyslipidemia.
Endocrinol Metab Clin North Am. 2006 Sep;35(3):491-510, vii-viii. doi: 10.1016/j.ecl.2006.06.002.
5
[Catabolism of lipoproteins].
Rev Clin Esp. 1985 May;176(9):433-41.
6
[New results in the clinical investigation of the fat metabolism].
Folia Clin Int (Barc). 1976 Oct;26(10):391-411.
7
[Lipoprotein metabolism].
Rev Med Brux. 1997 Feb;18(1):3-9.
8
Mechanisms of hyperlipoproteinemia.
Adv Exp Med Biol. 1972;26(0):57-70. doi: 10.1007/978-1-4684-7547-0_4.
9
[Structure and metabolism of lipoproteins].
Ann Biol Clin (Paris). 1986;44(5):531-5.
10
Role of the liver in hyperlipidemia.
Semin Liver Dis. 1992 Nov;12(4):356-63. doi: 10.1055/s-2008-1040405.
Zotero 插件